Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study.
Authors:
- E I SmithESE I Smith
- S ShochatSSS Shochat
- G AltshulerGAG Altshuler
- H TraversHTH Travers
- J J ShusterJSJ J Shuster
- F A HayesFHF A Hayes
- R PattersonRPR Patterson
- N McWilliamsNMN McWilliams
- 1 August 1988
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 6 (8) , 1271-1279
Abstract
A prospective study was designed to evaluate the outcome of patients with localized resectable neuroblastoma without regional lymph node involvement when no therapy beyond surgical resection was administered. One hundred one patients observed for 3 to 60 months had a 2-year disease-free survival of 89% (SE = 5%). Of the nine patients experiencing relapse, only three have died. There were no apparent distinguishing characteristics of the nine failures. Due to the favorable prognosis of the subset of neuroblastoma patients, prognostic factor analysis had very limited power and lacked clinical importance. Complete gross removal of the localized tumors is adequate therapy to ensure the survival of the majority of these patients.Keywords
This publication has 5 references indexed in Scilit:
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of NeuroblastomasJNCI: Journal of the National Cancer Institute, 1984
- Surgicopathologic staging of neuroblastoma: Prognostic significance of regional lymph node metastasesThe Journal of Pediatrics, 1983
- Total-body sequential segmental irradiation and combination chemotherapy for children with disseminated neuroblastomaCancer, 1976
- Factors influencing survival of children with nonmetastatic neuroblastomaCancer, 1976
- The Spectrum of Neurogenic Tumors of the Sympathetic Nervous System: Maturation and Adrenergic FunctionJNCI: Journal of the National Cancer Institute, 1965